PSCH holdings
Invesco S&P SmallCap Health Care ETF
Positions
81 stored of 81 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Invesco Private Prime Fund | Not reported | Not reported | 21.475% | $28.2M | Short-term investment vehicles (cash funds) | Private fund | United States | USD |
| 2 | Invesco Private Government Fund | Not reported | Not reported | 8.271% | $10.9M | Short-term investment vehicles (cash funds) | Private fund | United States | USD |
| 3 | Molina Healthcare, Inc. | US60855R1005 | 60855R100 | 4.767% | $6.3M | Equity (common) | Corporate | United States | USD |
| 4 | BrightSpring Health Services, Inc. | US10950A1060 | 10950A106 | 4.354% | $5.7M | Equity (common) | Corporate | United States | USD |
| 5 | Krystal Biotech, Inc. | US5011471027 | 501147102 | 4.253% | $5.6M | Equity (common) | Corporate | United States | USD |
| 6 | Alkermes PLC | IE00B56GVS15 | G01767105 | 3.715% | $4.9M | Equity (common) | Corporate | Ireland | USD |
| 7 | Corcept Therapeutics Inc. | US2183521028 | 218352102 | 3.469% | $4.6M | Equity (common) | Corporate | United States | USD |
| 8 | Glaukos Corp. | US3773221029 | 377322102 | 3.165% | $4.2M | Equity (common) | Corporate | United States | USD |
| 9 | PTC Therapeutics, Inc. | US69366J2006 | 69366J200 | 3.162% | $4.2M | Equity (common) | Corporate | United States | USD |
| 10 | Protagonist Therapeutics, Inc. | US74366E1029 | 74366E102 | 3.120% | $4.1M | Equity (common) | Corporate | United States | USD |
| 11 | Teleflex Inc. | US8793691069 | 879369106 | 3.032% | $4.0M | Equity (common) | Corporate | United States | USD |
| 12 | TG Therapeutics, Inc. | US88322Q1085 | 88322Q108 | 2.751% | $3.6M | Equity (common) | Corporate | United States | USD |
| 13 | Ligand Pharmaceuticals Inc. | US53220K5048 | 53220K504 | 2.435% | $3.2M | Equity (common) | Corporate | United States | USD |
| 14 | Indivior Pharmaceuticals, Inc. | US45579U1097 | 45579U109 | 2.398% | $3.2M | Equity (common) | Corporate | United States | USD |
| 15 | RadNet, Inc. | US7504911022 | 750491102 | 2.063% | $2.7M | Equity (common) | Corporate | United States | USD |
| 16 | Merit Medical Systems, Inc. | US5898891040 | 589889104 | 1.994% | $2.6M | Equity (common) | Corporate | United States | USD |
| 17 | Veracyte, Inc. | US92337F1075 | 92337F107 | 1.953% | $2.6M | Equity (common) | Corporate | United States | USD |
| 18 | Catalyst Pharmaceuticals, Inc. | US14888U1016 | 14888U101 | 1.924% | $2.5M | Equity (common) | Corporate | United States | USD |
| 19 | Organon & Co. | US68622V1061 | 68622V106 | 1.849% | $2.4M | Equity (common) | Corporate | United States | USD |
| 20 | ICU Medical, Inc. | US44930G1076 | 44930G107 | 1.782% | $2.3M | Equity (common) | Corporate | United States | USD |
| 21 | Integer Holdings Corp. | US45826H1095 | 45826H109 | 1.670% | $2.2M | Equity (common) | Corporate | United States | USD |
| 22 | Concentra Group Holdings Parent, Inc. | US20603L1026 | 20603L102 | 1.581% | $2.1M | Equity (common) | Corporate | United States | USD |
| 23 | Acadia Pharmaceuticals Inc. | US0042251084 | 004225108 | 1.446% | $1.9M | Equity (common) | Corporate | United States | USD |
| 24 | Supernus Pharmaceuticals, Inc. | US8684591089 | 868459108 | 1.412% | $1.9M | Equity (common) | Corporate | United States | USD |
| 25 | Privia Health Group, Inc. | US74276R1023 | 74276R102 | 1.326% | $1.7M | Equity (common) | Corporate | United States | USD |
| 26 | Alignment Healthcare, Inc. | US01625V1044 | 01625V104 | 1.308% | $1.7M | Equity (common) | Corporate | United States | USD |
| 27 | TransMedics Group, Inc. | US89377M1099 | 89377M109 | 1.225% | $1.6M | Equity (common) | Corporate | United States | USD |
| 28 | National HealthCare Corp. | US6359061008 | 635906100 | 1.221% | $1.6M | Equity (common) | Corporate | United States | USD |
| 29 | Waystar Holding Corp. | US9467841055 | 946784105 | 1.219% | $1.6M | Equity (common) | Corporate | United States | USD |
| 30 | Prestige Consumer Healthcare Inc. | US74112D1019 | 74112D101 | 1.199% | $1.6M | Equity (common) | Corporate | United States | USD |
| 31 | Amneal Pharmaceuticals, Inc. | US03168L1052 | 03168L105 | 1.192% | $1.6M | Equity (common) | Corporate | United States | USD |
| 32 | Arcus Biosciences, Inc. | US03969F1093 | 03969F109 | 1.145% | $1.5M | Equity (common) | Corporate | United States | USD |
| 33 | Acadia Healthcare Co., Inc. | US00404A1097 | 00404A109 | 1.141% | $1.5M | Equity (common) | Corporate | United States | USD |
| 34 | Progyny, Inc. | US74340E1038 | 74340E103 | 1.093% | $1.4M | Equity (common) | Corporate | United States | USD |
| 35 | Omnicell, Inc. | US68213N1090 | 68213N109 | 1.056% | $1.4M | Equity (common) | Corporate | United States | USD |
| 36 | LeMaitre Vascular, Inc. | US5255582018 | 525558201 | 1.053% | $1.4M | Equity (common) | Corporate | United States | USD |
| 37 | Neogen Corp. | US6404911066 | 640491106 | 1.040% | $1.4M | Equity (common) | Corporate | United States | USD |
| 38 | CorVel Corp. | US2210061097 | 221006109 | 1.027% | $1.3M | Equity (common) | Corporate | United States | USD |
| 39 | ADMA Biologics, Inc. | US0008991046 | 000899104 | 1.013% | $1.3M | Equity (common) | Corporate | United States | USD |
| 40 | Sarepta Therapeutics, Inc. | US8036071004 | 803607100 | 0.999% | $1.3M | Equity (common) | Corporate | United States | USD |
| 41 | Select Medical Holdings Corp. | US81619Q1058 | 81619Q105 | 0.970% | $1.3M | Equity (common) | Corporate | United States | USD |
| 42 | Pediatrix Medical Group, Inc. | US58502B1061 | 58502B106 | 0.967% | $1.3M | Equity (common) | Corporate | United States | USD |
| 43 | LifeStance Health Group, Inc. | US53228F1012 | 53228F101 | 0.928% | $1.2M | Equity (common) | Corporate | United States | USD |
| 44 | UFP Technologies, Inc. | US9026731029 | 902673102 | 0.905% | $1.2M | Equity (common) | Corporate | United States | USD |
| 45 | Vericel Corp. | US92346J1088 | 92346J108 | 0.899% | $1.2M | Equity (common) | Corporate | United States | USD |
| 46 | Addus HomeCare Corp. | US0067391062 | 006739106 | 0.892% | $1.2M | Equity (common) | Corporate | United States | USD |
| 47 | Astrana Health, Inc. | US03763A2078 | 03763A207 | 0.865% | $1.1M | Equity (common) | Corporate | United States | USD |
| 48 | Innoviva, Inc. | US45781M1018 | 45781M101 | 0.811% | $1.1M | Equity (common) | Corporate | United States | USD |
| 49 | Perrigo Co. PLC | IE00BGH1M568 | G97822103 | 0.811% | $1.1M | Equity (common) | Corporate | Ireland | USD |
| 50 | STAAR Surgical Co. | US8523123052 | 852312305 | 0.793% | $1.0M | Equity (common) | Corporate | United States | USD |
| 51 | Fortrea Holdings Inc. | US34965K1079 | 34965K107 | 0.758% | $996K | Equity (common) | Corporate | United States | USD |
| 52 | ANI Pharmaceuticals, Inc. | US00182C1036 | 00182C103 | 0.753% | $989K | Equity (common) | Corporate | United States | USD |
| 53 | NeoGenomics, Inc. | US64049M2098 | 64049M209 | 0.726% | $953K | Equity (common) | Corporate | United States | USD |
| 54 | Enovis Corp. | US1940145022 | 194014502 | 0.692% | $909K | Equity (common) | Corporate | United States | USD |
| 55 | Harmony Biosciences Holdings, Inc. | US4131971040 | 413197104 | 0.669% | $879K | Equity (common) | Corporate | United States | USD |
| 56 | Tandem Diabetes Care, Inc. | US8753722037 | 875372203 | 0.622% | $817K | Equity (common) | Corporate | United States | USD |
| 57 | Avanos Medical, Inc. | US05350V1061 | 05350V106 | 0.614% | $806K | Equity (common) | Corporate | United States | USD |
| 58 | AMN Healthcare Services, Inc. | US0017441017 | 001744101 | 0.593% | $780K | Equity (common) | Corporate | United States | USD |
| 59 | CONMED Corp. | US2074101013 | 207410101 | 0.590% | $774K | Equity (common) | Corporate | United States | USD |
| 60 | AdaptHealth Corp. | US00653Q1022 | 00653Q102 | 0.580% | $761K | Equity (common) | Corporate | United States | USD |
| 61 | Vir Biotechnology, Inc. | US92764N1028 | 92764N102 | 0.574% | $754K | Equity (common) | Corporate | United States | USD |
| 62 | Inspire Medical Systems, Inc. | US4577301090 | 457730109 | 0.574% | $753K | Equity (common) | Corporate | United States | USD |
| 63 | Integra LifeSciences Holdings Corp. | US4579852082 | 457985208 | 0.573% | $753K | Equity (common) | Corporate | United States | USD |
| 64 | Collegium Pharmaceutical, Inc. | US19459J1043 | 19459J104 | 0.567% | $744K | Equity (common) | Corporate | United States | USD |
| 65 | U.S. Physical Therapy, Inc. | US90337L1089 | 90337L108 | 0.521% | $684K | Equity (common) | Corporate | United States | USD |
| 66 | BioLife Solutions, Inc. | US09062W2044 | 09062W204 | 0.518% | $681K | Equity (common) | Corporate | United States | USD |
| 67 | Pacira Biosciences, Inc. | US6951271005 | 695127100 | 0.509% | $668K | Equity (common) | Corporate | United States | USD |
| 68 | Azenta, Inc. | US1143401024 | 114340102 | 0.500% | $657K | Equity (common) | Corporate | United States | USD |
| 69 | Artivion, Inc. | US2289031005 | 228903100 | 0.498% | $654K | Equity (common) | Corporate | United States | USD |
| 70 | QuidelOrtho Corp. | US2197981051 | 219798105 | 0.472% | $620K | Equity (common) | Corporate | United States | USD |
| 71 | Schrodinger, Inc. | US80810D1037 | 80810D103 | 0.455% | $597K | Equity (common) | Corporate | United States | USD |
| 72 | Xencor, Inc. | US98401F1057 | 98401F105 | 0.452% | $594K | Equity (common) | Corporate | United States | USD |
| 73 | Certara, Inc. | US15687V1098 | 15687V109 | 0.371% | $487K | Equity (common) | Corporate | United States | USD |
| 74 | Amphastar Pharmaceuticals, Inc. | US03209R1032 | 03209R103 | 0.356% | $467K | Equity (common) | Corporate | United States | USD |
| 75 | Phibro Animal Health Corp. Phibro Animal Health Corp., Class A | US71742Q1067 | 71742Q106 | 0.339% | $445K | Equity (common) | Corporate | United States | USD |
| 76 | HealthStream, Inc. | US42222N1037 | 42222N103 | 0.316% | $415K | Equity (common) | Corporate | United States | USD |
| 77 | Cytek Biosciences, Inc. | US23285D1090 | 23285D109 | 0.246% | $323K | Equity (common) | Corporate | United States | USD |
| 78 | Embecta Corp. | US29082K1051 | 29082K105 | 0.107% | $140K | Equity (common) | Corporate | United States | USD |
| 79 | Invesco Government & Agency Portfolio Invesco Government & Agency Portfolio, Institutional Class | US8252528851 | 825252885 | 0.044% | $58K | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |
| 80 | OmniAb, Inc. OmniAb, Inc., Rts., expiring 2027-11-02 | US68218J3014 | 68218J301 | 0.000% | $0 | Equity (common) | Corporate | United States | USD |
| 81 | OmniAb, Inc. OmniAb, Inc., Rts., 2027-11-02 | US68218J2024 | 68218J202 | 0.000% | $0 | Equity (common) | Corporate | United States | USD |